Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniae

The efficacy of oral telithromycin 800 mg once daily for 7 days was evaluated in a multicentre, multinational study in patients with community-acquired pneumonia caused by Streptococcus pneumoniae resistant to penicillin and/or erythromycin. Per-protocol clinical and bacteriological outcomes were as...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of infection 2005-10, Vol.51 (3), p.201-205
Hauptverfasser:	van Rensburg, Dirkie, Fogarty, Charles, De Salvo, María Cristina, Rangaraju, Manickam, Nusrat, Roomi
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Aged Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibacterial agents Antibiotic resistance Antibiotics. Antiinfectious agents. Antiparasitic agents Bacterial diseases Biological and medical sciences Community-Acquired Infections - drug therapy Community-Acquired Infections - microbiology Community-acquired pneumonia Drug Resistance, Bacterial Erythromycin - pharmacology Female Human bacterial diseases Humans Infectious diseases Ketolides - administration & dosage Ketolides - therapeutic use Male Medical sciences Microbial Sensitivity Tests Middle Aged Penicillin Resistance Penicillins - pharmacology Pharmacology. Drug treatments Pneumonia, Pneumococcal - drug therapy Pneumonia, Pneumococcal - microbiology Staphylococcal infections, streptococcal infections, pneumococcal infections Streptococcus pneumoniae Telithromycin Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!